Danaher Corporation $DHR Stake Lifted by Marks Group Wealth Management Inc

Marks Group Wealth Management Inc increased its position in shares of Danaher Corporation (NYSE:DHR) by 4.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,568 shares of the conglomerate’s stock after purchasing an additional 239 shares during the period. Marks Group Wealth Management Inc’s holdings in Danaher were worth $1,100,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. raised its stake in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC grew its holdings in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new stake in Danaher in the first quarter worth about $31,000. Dunhill Financial LLC lifted its holdings in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Finally, Costello Asset Management INC acquired a new stake in Danaher in the 1st quarter valued at about $41,000. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $211.65 on Tuesday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $151.55 billion, a PE ratio of 45.03, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The business has a fifty day simple moving average of $200.36 and a 200-day simple moving average of $197.24.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the prior year, the business earned $1.72 EPS. The business’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on DHR shares. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Evercore ISI dropped their price target on Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Bank of America reduced their price objective on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Robert W. Baird increased their price target on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $245.91.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.